These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26694149)

  • 21. Peripheral neuropathy in obstetrics: efficacy and safety of α-lipoic acid supplementation.
    Costantino M; Guaraldi C; Costantino D; De Grazia S; Unfer V
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2766-71. PubMed ID: 25317815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects.
    Carlson DA; Smith AR; Fischer SJ; Young KL; Packer L
    Altern Med Rev; 2007 Dec; 12(4):343-51. PubMed ID: 18069903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes.
    Evans JL; Goldfine ID
    Diabetes Technol Ther; 2000; 2(3):401-13. PubMed ID: 11467343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the analgesic effect of ɑ-lipoic acid in treating pain disorders: A systematic review and meta-analysis of randomized controlled trials.
    Cassanego G; Rodrigues P; De Freitas Bauermann L; Trevisan G
    Pharmacol Res; 2022 Mar; 177():106075. PubMed ID: 35026405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo effect of lipoic acid on lipid peroxidation in patients with diabetic neuropathy.
    Androne L; Gavan NA; Veresiu IA; Orasan R
    In Vivo; 2000; 14(2):327-30. PubMed ID: 10836205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson's disease: a review.
    De Araújo DP; Lobato Rde F; Cavalcanti JR; Sampaio LR; Araújo PV; Silva MC; Neves KR; Fonteles MM; Sousa FC; Vasconcelos SM
    Int J Neurosci; 2011 Feb; 121(2):51-7. PubMed ID: 21126109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis.
    Orellana-Donoso M; López-Chaparro M; Barahona-Vásquez M; Santana-Machuca A; Bruna-Mejias A; Nova-Baeza P; Valenzuela-Fuenzalida JJ
    Medicine (Baltimore); 2023 Nov; 102(44):e35368. PubMed ID: 37933068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of oral alpha-lipoic acid on oxidative stress in adolescents with type 1 diabetes mellitus.
    Huang EA; Gitelman SE
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 2):69-73. PubMed ID: 18221433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy.
    Foster TS
    Diabetes Educ; 2007; 33(1):111-7. PubMed ID: 17272797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study).
    Tankova T; Koev D; Dakovska L
    Rom J Intern Med; 2004; 42(2):457-64. PubMed ID: 15529636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is it time to reassess alpha lipoic acid and niacinamide therapy in schizophrenia?
    Seybolt SE
    Med Hypotheses; 2010 Dec; 75(6):572-5. PubMed ID: 20708342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of α-lipoic acid on mtDNA damage after isolated muscle contractions.
    Fogarty MC; Devito G; Hughes CM; Burke G; Brown JC; McEneny J; Brown D; McClean C; Davison GW
    Med Sci Sports Exerc; 2013 Aug; 45(8):1469-77. PubMed ID: 23470303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy.
    Femiano F; Scully C
    J Oral Pathol Med; 2002 May; 31(5):267-9. PubMed ID: 12110042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Burning mouth syndrome: the efficacy of lipoic acid on subgroups.
    Femiano F; Gombos F; Scully C
    J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):676-8. PubMed ID: 15482293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes.
    Rochette L; Ghibu S; Muresan A; Vergely C
    Can J Physiol Pharmacol; 2015 Dec; 93(12):1021-7. PubMed ID: 26406389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pro-oxidant actions of alpha-lipoic acid and dihydrolipoic acid.
    Cakatay U
    Med Hypotheses; 2006; 66(1):110-7. PubMed ID: 16165311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution study of orally administered lipoic acid in rat brain tissues.
    Chng HT; New LS; Neo AH; Goh CW; Browne ER; Chan EC
    Brain Res; 2009 Jan; 1251():80-6. PubMed ID: 19046949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of improvement and progression of diabetic polyneuropathy following treatment with α-lipoic acid for 4 years in the NATHAN 1 trial.
    Ziegler D; Low PA; Freeman R; Tritschler H; Vinik AI
    J Diabetes Complications; 2016 Mar; 30(2):350-6. PubMed ID: 26651260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoic acid in animal models and clinical use in diabetic retinopathy.
    Nebbioso M; Pranno F; Pescosolido N
    Expert Opin Pharmacother; 2013 Sep; 14(13):1829-38. PubMed ID: 23790257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of therapy with alpha-lipoic acid (ALA) on the oxidative stress in the controlled NIDDM: a possible preventive way against the organ dysfunction?
    Gianturco V; Bellomo A; D'Ottavio E; Formosa V; Iori A; Mancinella M; Troisi G; Marigliano V
    Arch Gerontol Geriatr; 2009; 49 Suppl 1():129-33. PubMed ID: 19836626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.